Publication

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

BMC Gastroenterology 20:210, 2020

Hansen HH, Ægidius HM, Oró D, Evers S, Heebøll S, Eriksen PL, Bengtsson A, Veidal SS, Feigh M, Knop FK, Grønbæk H, Miranda D, Trevaskis JL, Vrang N, Jelsing J, Rigbolt KTG

Subjects
GAN DIO-MASH mouseHumanTherapeutic AreaMouseMethod/EndpointSpeciesBody compositionBody weightBlood biochemistryBioinformaticsMetabolic dysfunction-associated steatohepatitisHistopathology scoreIntraperitoneal glucose tolerance test (IPGTT)Image analysisImmunohistochemistry (IHC)Liver biopsyLiver morphometryRNA sequencing

Share this page

Resource Library

Related resources
Publication
Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis
Poster
Characterization of resmetirom in the CDAA-HFD mouse model of advanced NASH with progressive fibrosis
Publication
Bariatric surgery in patients with non-alcoholic fatty liver disease – from pathophysiology to clinical effects
Publication
The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top